Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

N/AAvailableNCT05561985

Incyte Corporation

Overview

Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Study Type

EXPANDED_ACCESS

Medical Language ↔ Plain English

Inclusion Criteria: \- Exclusion Criteria: \-

Incyte Corporation Call Center (US)

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.